•] Shares OCEAN BIOMEDICAL INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 22nd, 2021 • Ocean Biomedical, Inc. • Pharmaceutical preparations • New York
EXCLUSIVE LICENSE AGREEMENT BROWN ID 3039 - Bi Specific Antibody Anti-CTLA4Exclusive License Agreement • June 22nd, 2021 • Ocean Biomedical, Inc. • Pharmaceutical preparations • Rhode Island
This Exclusive License Agreement (this “Agreement”) is entered into as of July 31, 2020 (the “Effective Date”), by and between Elkurt Inc. a Delaware corporation, with an address at 297 President Ave, Providence RI 02906 (“Elkurt”) and Ocean Biomedical Inc, a Delaware corporation with an address at 19W060 Avenue LaTours, Oak Brook, IL 60523 (“Licensee”).
